key: cord-0899901-p16hxz9e
authors: Kim, Sooyeol; Kennedy, Lauren C.; Wolfe, Marlene K.; Criddle, Craig S.; Duong, Dorothea H.; Topol, Aaron; White, Bradley J.; Kantor, Rose S.; Nelson, Kara L.; Steele, Joshua A.; Langlois, Kylie; Griffith, John F.; Zimmer-Faust, Amity G.; McLellan, Sandra L.; Schussman, Melissa K.; Ammerman, Michelle; Wigginton, Krista R.; Bakker, Kevin M.; Boehm, Alexandria B.
title: SARS-CoV-2 RNA is enriched by orders of magnitude in primary settled solids relative to liquid wastewater at publicly owned treatment works
date: 2022-02-15
journal: Environmental science : water research & technology
DOI: 10.1039/d1ew00826a
sha: ff08252c52e581cb1b88f22a98ef96a30945a01f
doc_id: 899901
cord_uid: p16hxz9e

Wastewater-based epidemiology has gained attention throughout the world for detection of SARS-CoV-2 RNA in wastewater to supplement clinical testing. Raw wastewater consists of small particles, or solids, suspended in liquid. Methods have been developed to measure SARS-CoV-2 RNA in the liquid and the solid fraction of wastewater, with some studies reporting higher concentrations in the solid fraction. To investigate this relationship further, six laboratories collaborated to conduct a study across five publicly owned treatment works (POTWs) where both primary settled solids obtained from primary clarifiers and raw wastewater influent samples were collected and quantified for SARS-CoV-2 RNA. Settled solids and influent samples were processed by participating laboratories using their respective methods and retrospectively paired based on date of collection. SARS-CoV-2 RNA concentrations, on a mass equivalent basis, were higher in settled solids than in influent by approximately three orders of magnitude. Concentrations in matched settled solids and influent were positively and significantly correlated at all five POTWs. RNA concentrations in both settled solids and influent were correlated to COVID-19 incidence rates in the sewersheds and thus representative of disease occurrence; the settled solids methods appeared to produce a comparable relationship between SARS-CoV-2 RNA concentration measurements and incidence rates across all POTWs. Settled solids and influent methods showed comparable sensitivity, N gene detection frequency, and calculated empirical incidence rate lower limits. Analysis of settled solids for SARS-CoV-2 RNA has the advantage of using less sample volume to achieve similar sensitivity to influent methods.

PCR kits were used with a BioRad QX200 AutoDG droplet digital PCR system (BioRad, CA). 74 Full methods for OS solids are in Wolfe et al. 1  75  76 For SB, OC, and JI, N1 and N2 were quantified using a duplex assay with undiluted NA 77 template; each of the two replicate extractions were run in triplicate wells for a total of six wells 78 per sample. Nine no-template controls (NTCs) were included on each plate. N1 and N2 positive 79 controls were run in two wells per plate and consisted of NA from a nasopharynx swab of a 80

high-titer patient from Stanford Hospital. For samples from the same POTWs, PMMoV and 81

BCoV were quantified using a duplex assay with 1:100 diluted template; each of the two 82

replicate extractions was run in one well for a total of two wells per sample. Four NTCs were 83 included on each plate. Positive controls for BCoV (direct extraction of BCoV vaccine diluted to 84 ~10 6 cp/mL) and PMMoV (synthetic DNA ultramer from IDT) were included in two wells each. 85

Replicate wells were merged and processed in QuantaSoft and QuantaSoft Analysis Pro 86 (BioRad, CA) to manually threshold and export data as described in Graham et al. 2  87  88 For AA, N1 and N2 were quantified using a duplex assay with undiluted NA template; each of 89 the three replicate extractions were run in one well for a total of three wells per sample. At least 90 three wells of NTC were included on each plate, and N1 and N2 positive controls were run in 91 three wells per plate (IDT plasmids). PMMoV and BCoV were quantified using a duplex assay 92 with 1:100 diluted NA template; each of the three replicate extractions was run in one well for a 93 total of three wells per sample. At least three wells of NTC were included on each plate; three 94 wells of positive control (PMMoV synthetic DNA ultramer from IDT and BCoV spiked in water) 95 were included on each plate, QuantaSoft and QuantaSoftAnalysis Pro (BioRad, CA) were used 96 to manually threshold and export data. 97 98

The required number of droplets was 10,000 for individual wells; any samples with fewer 99 droplets were rerun or not included in the final analysis. Merged wells with three or more 100 positive droplets were deemed positive. For a plate to be included in further analysis, merged 101

NTCs were required to have no more than two positive droplets. Any samples that did not return 102 a value for PMMoV or BCoV were not included in the final analysis, assuming failed extraction. 103

Six samples for JI were excluded based on these criteria. 104 105 SB, OC influent 106

Following the methods described in Steel et al., 3 500 mL of raw influent was acidified by adding 107 20% HCl to achieve pH of 3.5 or less. (Design and analysis software v1.5.1) with thermocycling conditions in Table S9.  177  178 For the N1 assay, the limit of detection was assessed using the DNA standards to be 4 gene 179 copies per reaction (gc/rxn). For BCoV and PMMoV, it was set at the bottom of the standard 180 curve, which no samples fell below. Negative controls were all below the detection limit or had a 181

higher Cq value than the lowest standard run. Individual standard curves were combined into 182 master standard curves for each assay (Table S10) In order to convert from X copies/uL from ddPCR to Y copies/g dry weight, the following 198 equation was used for all samples. 199

Influent 204

For SB, OC, and JI, the following equation was used to convert copies/uL from ddPCR to 205 copies/L wastewater. 206

For OS, the following equation was used for all samples with a dilution factor of 1 or 5. 211

For AA, 216

Lower measurement limit.

AA solids and OS solids lower measurement limit was calculated by the respective lab and 222

reported based on the concentration that would be obtained with three positive droplets in 223 ddPCR. For OS influent, lower measurement limit was assessed using DNA standards with 224 qPCR, as described above. For all other data sets, the lower measurement limit for individual 225 samples were calculated based on the three positive droplet cut-off and the average was 226

reported. Additionally, for AA influent, different amounts of water was used when resuspending 227 the viral PEG pellet, resulting in a unique effective volume for all samples. For JI influent, as the 228 procedure evolved, the effective volume associated with the sample also differed. In both of 229 these cases, an average of the lower measurement limit was calculated and reported. Lower 230 measurement limit for data sets in this study are shown in Table S4 . by PMMoV and laboratory-confirmed SARS-CoV-2 incidence rate for each of the five POTWs 275 over their respective duration of sample collection. N was measured for OS solids and N1 for all 276 other data sets. Points represent individual data points. Samples above the lower measurement 277 limit are shown as filled circles. Samples that resulted in ND, shown as empty circles, were 278 substituted with a value half of the lower measurable limit. Lines for solid and influent are locally 279 weighted scatterplot smoothing (lowess) with value of that minimizes the residual for each 280 dataset (Table S6 ). 9 Lines for COVID-19 incidence rates are 7-day centered smoothed 281 averages. 282 283 Table_S8. values used to plot lowess lines in Figure 2 (in column N1/PMMoV or N/PMMoV) 322

and Figure S5 

Throughput Quantification of SARS-CoV-2 RNA in Wastewater Settled Solids at Eight Publicly 373 Owned Treatment Works in Northern California Shows Strong Association with COVID-19

SARS-CoV-2 RNA in Wastewater Settled Solids Is Associated 378 with COVID-19 Cases in a Large Urban Sewershed

Sources of variability in 381 methods for processing, storing, and concentrating SARS-CoV-2 in influent from urban 382 wastewater treatment plants, Public and Global Health

Evaluation of Sampling, Analysis, and Normalization Methods for SARS-CoV-2 385 Concentrations in Wastewater to Assess COVID-19 Burdens in Wisconsin Communities

Methods Evaluation for Rapid 388 Concentration and Quantification of SARS-CoV-2 in Raw Wastewater Using Droplet Digital 389 and Quantitative RT-PCR

Operationalizing a routine wastewater monitoring 392 laboratory for SARS-CoV-2, Epidemiology

(4S): An Economical Kit-Free Method for Direct Capture of SARS-396

CoV-2 RNA from Wastewater

Tools for interpretation of wastewater SARS-CoV-2 temporal and spatial trends demonstrated 403 with data collected in the San Francisco Bay Area